{"id":28579,"date":"2023-12-08T16:52:31","date_gmt":"2023-12-08T16:52:31","guid":{"rendered":"https:\/\/www.curiumpharma.com\/?page_id=28579"},"modified":"2024-11-05T16:26:39","modified_gmt":"2024-11-05T16:26:39","slug":"solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer","status":"publish","type":"page","link":"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/","title":{"rendered":"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&#038;T PET\/CT in Men with Biochemical Recurrence of Prostate Cancer"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":89,"featured_media":0,"parent":0,"menu_order":20,"comment_status":"closed","ping_status":"closed","template":"template-single-trial.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-28579","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&amp;T PET\/CT in Men with Biochemical Recurrence of Prostate Cancer - Curium Pharma<\/title>\n<meta name=\"description\" content=\"A Phase 3 Study - Test the Diagnostic Performance of Copper Cu 64 PSMA I&amp;T PET\/CT with Biochemical Recurrence of Prostate Cancer\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&amp;T PET\/CT in Men with Biochemical Recurrence of Prostate Cancer - Curium Pharma\" \/>\n<meta property=\"og:description\" content=\"A Phase 3 Study - Test the Diagnostic Performance of Copper Cu 64 PSMA I&amp;T PET\/CT with Biochemical Recurrence of Prostate Cancer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Curium Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-05T16:26:39+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/fr\\\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\\\/\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/fr\\\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\\\/\",\"name\":\"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\\\/CT in Men with Biochemical Recurrence of Prostate Cancer - Curium Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\"},\"datePublished\":\"2023-12-08T16:52:31+00:00\",\"dateModified\":\"2024-11-05T16:26:39+00:00\",\"description\":\"A Phase 3 Study - Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\\\/CT with Biochemical Recurrence of Prostate Cancer\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/fr\\\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curiumpharma.com\\\/fr\\\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/fr\\\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curiumpharma.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&#038;T PET\\\/CT in Men with Biochemical Recurrence of Prostate Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/\",\"name\":\"Curium Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curiumpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\/CT in Men with Biochemical Recurrence of Prostate Cancer - Curium Pharma","description":"A Phase 3 Study - Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\/CT with Biochemical Recurrence of Prostate Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/","og_locale":"fr_FR","og_type":"article","og_title":"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\/CT in Men with Biochemical Recurrence of Prostate Cancer - Curium Pharma","og_description":"A Phase 3 Study - Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\/CT with Biochemical Recurrence of Prostate Cancer","og_url":"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/","og_site_name":"Curium Pharma","article_modified_time":"2024-11-05T16:26:39+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/","url":"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/","name":"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\/CT in Men with Biochemical Recurrence of Prostate Cancer - Curium Pharma","isPartOf":{"@id":"https:\/\/www.curiumpharma.com\/#website"},"datePublished":"2023-12-08T16:52:31+00:00","dateModified":"2024-11-05T16:26:39+00:00","description":"A Phase 3 Study - Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET\/CT with Biochemical Recurrence of Prostate Cancer","breadcrumb":{"@id":"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.curiumpharma.com\/fr\/solar-recur-a-phase-3-cu-64-psma-pet-ct-prostate-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curiumpharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&#038;T PET\/CT in Men with Biochemical Recurrence of Prostate Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.curiumpharma.com\/#website","url":"https:\/\/www.curiumpharma.com\/","name":"Curium Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curiumpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.curiumpharma.com\/fr\/wp-json\/wp\/v2\/pages\/28579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curiumpharma.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.curiumpharma.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/fr\/wp-json\/wp\/v2\/users\/89"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/fr\/wp-json\/wp\/v2\/comments?post=28579"}],"version-history":[{"count":0,"href":"https:\/\/www.curiumpharma.com\/fr\/wp-json\/wp\/v2\/pages\/28579\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.curiumpharma.com\/fr\/wp-json\/wp\/v2\/media?parent=28579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}